Benzinga | Dec 9, 2021 09:38PM EST

AstraZeneca Shares Quiet Following Report FDA Authorized New Long-Acting Monoclonal Antibodies For Pre-Exposure Prevention Of COVID-19 In Certain Individuals

-Reuters